Clinical Trial Update: CLN-0046: Treatment of AMD Subjects With OTX-TKI [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CLN-0046 (OTX-TKI) in neovascular age-related macular degeneration, reporting results from subjects treated with the investiga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• OTX-TKI

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Neovascular Age-related Macular Degeneration | Phase 1 | Status: COMPLETED